University of California San Francisco
Give to UCSFLearn about UCSF’s response to the coronavirus outbreak, important updates on campus safety precautions, and the latest policies and guidance on our COVID-19 resource website. You can also access information from the CDC. Learn more
New results from an ongoing collaborative effort to slow the spread of COVID-19 shows that the prevalence of a coronavirus lineage, characterized by the L452R substitution and two other mutations in the virus’s spike protein, has significantly increased in recent months.
We turned to UCSF scientists to better understand probiotics and the human microbiome they aim to influence.
Susan Acton discovered ACE2 while searching for new cardiovascular drugs. Decades later, she was surprised to see it popping up in the news once COVID took hold.
The vaccination site builds off previous work with Unidos en Salud to bring COVID-19 testing to the Mission District.
A UCSF team has engineered a tiny antibody capable of neutralizing the coronavirus.
As its supply of COVID-19 vaccines increases, UC San Francisco is expanding its vaccination efforts to those most at risk – the elderly and health care workers in the community
We posed the most common COVID-19 vaccine quandaries to Bryn Boslett, MD, an infectious disease expert who is leading the vaccination effort at UCSF. She explains why mRNA vaccines won’t affect your DNA, which allergies pose a risk, what 95 percent efficacy really means, and more.
In two preclinical models of COVID-19, plitidepsin showed a 100-fold reduction in viral replication in the lungs and demonstrated an ability to reduce lung inflammation.
Patients with severe COVID-19 produce antibodies that paradoxically shut down their immune system’s virus-fighting response just when they need it most.
Few would have predicted last January that a pandemic would upend our daily lives. But one grueling year in, UCSF experts have a clearer view of the path ahead.
“It’s too soon to know if this variant will spread more rapidly than others," said Erica Pan, MD, MPH, State Epidemiologist for the California Department of Public Health.
Scientists at UCSF have developed ReScan, an innovative new serological test that employs a specialized version of the technique known as phage display.
A mutated version of the novel coronavirus has been making the news for being more contagious. We asked UCSF infectious disease expert Charles Chiu, MD, PhD, how the new variant emerged, whether available vaccines will still work, and what we need to do now.
UCSF Medical Center has begun administering second doses of the Pfizer COVID-19 vaccine to frontline employees who are at highest risk of exposure to COVID-19 at work.
A UCSF pediatrician who is researching methods to control the spread of coronavirus shares why she’s optimistic that schools can reopen safely.